Total Payments
$5,596
2024 Payments
$1,890
Companies
25
Transactions
283
Medicare Patients
3,856
Medicare Billing
$283,048
Payment Breakdown by Category
Food & Beverage$5,371 (96.0%)
Education$225.14 (4.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,371 | 280 | 96.0% |
| Education | $225.14 | 3 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $645.97 | 35 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $630.04 | 20 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $497.71 | 39 | $0 (2024) |
| Dermavant Sciences, Inc. | $433.30 | 40 | $0 (2024) |
| Incyte Corporation | $400.15 | 14 | $0 (2024) |
| Amgen Inc. | $381.33 | 14 | $0 (2024) |
| PFIZER INC. | $374.72 | 19 | $0 (2024) |
| Janssen Biotech, Inc. | $362.73 | 17 | $0 (2024) |
| UCB, Inc. | $228.36 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $221.88 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,890 | 103 | Dermavant Sciences, Inc. ($265.42) |
| 2023 | $1,759 | 91 | Regeneron Healthcare Solutions, Inc. ($308.66) |
| 2022 | $976.49 | 47 | ABBVIE INC. ($294.78) |
| 2021 | $970.99 | 42 | AbbVie Inc. ($228.92) |
All Payment Transactions
283 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $3.28 | General |
| Category: Inflammation & Immunology | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $37.65 | General |
| Category: Immunology | ||||||
| 12/16/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $3.49 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $30.58 | General |
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.77 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Immunology | ||||||
| 11/25/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.45 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: ACNE | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.75 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.01 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/08/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $34.53 | General |
| Category: DERMATOLOGY | ||||||
| 11/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: DERMATOLOGY | ||||||
| 11/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $1.03 | General |
| Category: DERMATOLOGY | ||||||
| 10/28/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.99 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.43 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.77 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.88 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,320 | 2,438 | $258,513 | $96,572 |
| 2022 | 15 | 1,068 | 2,071 | $203,354 | $73,630 |
| 2021 | 14 | 958 | 1,816 | $194,894 | $74,285 |
| 2020 | 13 | 510 | 900 | $94,014 | $38,560 |
Total Patients
3,856
Total Services
7,225
Medicare Billing
$283,048
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 250 | 411 | $59,181 | $22,960 | 38.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 166 | 236 | $43,784 | $17,585 | 40.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 175 | 175 | $31,279 | $11,839 | 37.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 154 | 188 | $31,127 | $10,458 | 33.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 200 | 279 | $30,312 | $9,152 | 30.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 25 | 27 | $13,280 | $5,570 | 41.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 31 | 47 | $12,775 | $5,298 | 41.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 145 | 876 | $9,468 | $3,984 | 42.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 64 | 80 | $7,251 | $3,020 | 41.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 22 | $4,464 | $1,983 | 44.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 42 | 48 | $3,933 | $1,739 | 44.2% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 15 | $5,958 | $1,328 | 22.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 23 | 23 | $2,671 | $980.66 | 36.7% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $3,030 | $674.48 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 181 | 287 | $42,044 | $16,270 | 38.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 136 | 179 | $33,801 | $13,445 | 39.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 157 | 157 | $28,506 | $10,306 | 36.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 166 | 243 | $26,941 | $7,583 | 28.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 105 | 126 | $21,472 | $6,912 | 32.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 31 | 39 | $10,797 | $3,955 | 36.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 134 | 859 | $9,570 | $3,861 | 40.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 13 | 15 | $7,470 | $3,161 | 42.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 27 | $5,555 | $2,343 | 42.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 46 | 59 | $5,414 | $2,005 | 37.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,960 | $1,320 | 44.6% |
About Molly Warnock
Molly Warnock is a Physician Assistant healthcare provider based in Annapolis, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2020. The National Provider Identifier (NPI) number assigned to this provider is 1821628751.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Molly Warnock has received a total of $5,596 in payments from pharmaceutical and medical device companies, with $1,890 received in 2024. These payments were reported across 283 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($5,371).
As a Medicare-enrolled provider, Warnock has provided services to 3,856 Medicare beneficiaries, totaling 7,225 services with total Medicare billing of $283,048. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Other Specialties Medical
- Location Annapolis, MD
- Active Since 01/20/2020
- Last Updated 12/14/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1821628751
Products in Payments
- DUPIXENT (Biological) $971.54
- Sotyktu (Drug) $497.71
- VTAMA (Drug) $433.30
- OPZELURA (Drug) $400.15
- TREMFYA (Drug) $362.73
- SKYRIZI (Biological) $362.35
- EUCRISA (Drug) $354.30
- Otezla (Drug) $275.86
- TALTZ (Drug) $180.64
- Cimzia (Drug) $162.52
- RINVOQ (Biological) $138.74
- ADBRY (Biological) $136.92
- COSENTYX (Drug) $134.26
- HUMIRA (Biological) $117.34
- Enbrel (Biological) $105.47
- Bimzelx (Biological) $65.84
- Zoryve (Drug) $64.44
- CLODERM (Drug) $58.12
- Klisyri (Drug) $56.78
- ImmunoCAP (Device) $49.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Annapolis
Karen Scott, Pa, PA
Physician Assistant — Payments: $32,733
Physician Assistant $32,733
Lisa Fox, Pa C, PA C
Physician Assistant — Payments: $23,418
Physician Assistant $23,418
Andrew Marsella
Physician Assistant — Payments: $14,677
Physician Assistant $14,677
Julie Catlin, Pa-C, PA-C
Physician Assistant — Payments: $13,245
Physician Assistant $13,245
Ms. Melissa Veneracion, Pa-C, PA-C
Physician Assistant — Payments: $12,681
Physician Assistant $12,681
Nathan Turner
Physician Assistant — Payments: $8,170
Physician Assistant $8,170